Vaccine: Clinical Trials

41 trials of Vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 8 unknown, 4 active not recruiting, 4 recruiting. 15 Phase 2, 8 Phase 1, 7 Phase 3, 6 Phase 4, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 215Completed 8, Terminated 2, Withdrawn 2, Active not recruiting 1, Recruiting 1, Unknown 1
Phase 18Active not recruiting 2, Completed 2, Withdrawn 2, Recruiting 1, Unknown 1
Phase 37Completed 4, Recruiting 1, Terminated 1, Unknown 1
Phase 46Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1
Not applicable3Completed 2, Withdrawn 1
Early Phase 11Completed 1

Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.
Vaccine, Placebo - RSV Infections, RSV Immunisation
Phase 3RecruitingUniversity of Witwatersrand, South Africa130002025-09-032026-05-18
Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers
Vaccine - Dengue
Early Phase 1CompletedPrince of Songkla University292025-04-192026-10-02
Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).
Vaccine - Dengue
Active not recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS302024-06-302025-09-05
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
vaccine - Aging
Phase 4RecruitingState University of New York at Buffalo602024-01-082026-04-03
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
Vaccine - Recurrent Vulvovaginal Candidiasis
Phase 1 / Phase 2Active not recruitingLimmaTech Biologics AG2512023-12-062026-03-04
A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
Vaccine, Placebo - Post-kala-azar Dermal Leishmaniasis
Phase 2WithdrawnUniversity of York2023-10-012022-09-30
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Vaccine - Solid Tumor, Adult
Phase 2UnknownPeking Union Medical College Hospital202023-08-012023-08-14
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Vaccine - Pediatric Cancer
Phase 2RecruitingWake Forest University Health Sciences642022-08-082026-07-23
Comparison of Clinical Outcome Among Vaccinated and Unvaccinated Coronavirus Disease Patients in Critical Care Unit.
Vaccine - Coronavirus Infections, Critical Illness
UnknownCivil Service Hospital of Nepal2002022-04-152022-04-18
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)
V110, V114, mRNA-1273 - Pneumococcal Infection
Phase 3CompletedMerck Sharp & Dohme LLC8502022-01-122025-07-18
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
rHSC-DIPGVax, Balstilimab, Zalifrelimab - Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Phase 1RecruitingAnn & Robert H Lurie Children's Hospital of Chicago362022-01-102026-03-17
Effect of COVID-19 Pandemic on Vaccination Compliance
vaccine - Vaccine Refusal
UnknownAssiut University1002021-12-012021-08-03
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
Vaccine - Safety, Immunogenicity, Vaccine
Phase 4UnknownCenters for Disease Control and Prevention, China30002021-10-082022-03-28
A Study to Test Three Experimental HIV Vaccines in Healthy Adults.
Vaccine, Placebo - HIV-1-infection
Phase 1UnknownUniversity of Oxford882021-08-162022-06-22
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
Vaccine - Rotavirus Gastroenteritis, Rotavirus Vaccines
CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)16002021-05-042025-03-18
Factor Affecting Childhood Immunization Among Childern.
vaccine - Child Immunization
UnknownAssiut University502021-01-012020-04-01
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics, CELLECTRA®2000 EP Device supplied by Geneos Therapeutics, Plasmid encoded IL-12 - Glioblastoma
Phase 1Active not recruitingWashington University School of Medicine92020-07-142026-05-07
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Blood sample collection, Tumor biopsies, CT scan - Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer
Phase 2CompletedCentre Hospitalier Universitaire de Besancon472020-02-182024-12-20
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
HER2 DC1 Vaccine - Breast Cancer, HER2-positive Breast Cancer
Phase 2TerminatedH. Lee Moffitt Cancer Center and Research Institute162019-01-102022-04-25
Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)
Vaccine - HPV - Anogenital Human Papilloma Virus Infection, HIV Infections
Phase 4Active not recruitingCentre Hospitalier Universitaire Saint Pierre1702018-01-082025-02-17

Showing 20 of 41. Sign in to see all of them.

Conditions studied

Influenza, Human (8)  ·  Breast Neoplasms (3)  ·  Coronavirus Infections (2)  ·  Dengue (2)  ·  Neoplasms (2)  ·  Adenoviridae Infections (1)  ·  Anal Canal Carcinoma (1)  ·  Breast Neoplasms, Male (1)  ·  COVID-19 (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diarrhea, Infantile (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  H. Lee Moffitt Cancer Center and Research Institute (3)  ·  Assiut University (2)  ·  Pfizer (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Centers for Disease Control and Prevention, China (1)  ·  Centre Hospitalier Universitaire Saint Pierre (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Civil Service Hospital of Nepal (1)  ·  Fluart Innovative Vaccine Ltd, Hungary (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Hadassah Medical Organization (1)  ·  Institute of Virology, Vaccines and Sera, Torlak (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)

Countries

United States (12)  ·  France (5)  ·  Belgium (2)  ·  Canada (2)  ·  China (2)  ·  Germany (2)  ·  Ghana (2)  ·  Hungary (2)  ·  Italy (2)  ·  Kenya (2)  ·  Poland (2)  ·  Spain (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Zambia (2)

Top investigators

Allison J McGeer, MD (1)  ·  Anna Osi, Dr. (1)  ·  Ashley Hinson, MD (1)  ·  Ashley Plant-Fox, MD (1)  ·  Bernie Endyarni, MD (1)  ·  Brian Czerniecki, M.D., Ph.D. (1)  ·  Carlo Torti, Prof (1)  ·  Deborah Konopnicki, MD, PhD (1)  ·  Deepak Bhandari, MD (1)  ·  Desmond A Schatz, MD (1)  ·  Dung Le, M.D. (1)  ·  Eduard Sanders, MD (1)  ·  Elsa N Bou Ghanem, PhD (1)

Results publications

PMID 19416838, PMID 19875605, PMID 20018367, PMID 22011412, PMID 23563266, PMID 23764537, PMID 24690681, PMID 26351392, PMID 26407272, PMID 26815709, PMID 28003809, PMID 29551225, PMID 31535129, PMID 32518891, PMID 32681472, PMID 35164991, PMID 35928870, PMID 37125490, PMID 38140184, PMID 38245116, PMID 39229259, PMID 40006738, PMID 40356381, PMID 40388952, PMID 42120910

NIH funding

2009 (1), 2014 (1), 2023 (1), R01AG068568 (1), R01NS112712 (1)